VISIONFLEX PTY. LTD.

VisionFlex Pty. Ltd. specializes in two primary device categories: modular data memory units for patient monitoring systems and surgical camera lenses. The data memory units store and manage clinical data, aiding in diagnostics and treatment decisions, while the surgical camera lenses provide high-resolution imaging for minimally invasive procedures in operating rooms. These devices are designed to integrate seamlessly into existing medical workflows.

VisionFlex Pty. Ltd. operates with a presence in the United States. Since its devices are intended for use in the US market, they must comply with applicable regulations, including those governed by the FDA. The company’s devices are registered in the FDA’s Unique Device Identifier (UDI) database, which is a requirement for tracking and transparency in the medical device industry. Compliance ensures that the devices meet safety, performance, and quality standards.

VisionFlex Pty. Ltd.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is critical because it provides a standardized way to identify medical devices throughout their lifecycle, from manufacturing to post-market surveillance. The UDI system helps healthcare providers, regulators, and manufacturers track devices for safety monitoring, recalls, and compliance verification, ensuring transparency and accountability in the medical device supply chain.

All of VisionFlex Pty. Ltd.’s devices fall under Class I classification in the FDA’s regulatory framework. Class I devices are generally considered to pose the lowest risk and typically involve minimal potential for harm to the user. This classification means that while they still must comply with FDA requirements—such as registration, listing, and adherence to general controls—they do not require pre-market approval or stringent post-market surveillance beyond standard regulatory oversight. The classification reflects the devices’ intended use and risk profile.